Point-of-Care Testing Emerges as Key in Cardiovascular Risk Management in Vienna

2025-08-11 prevention

Vienna, Monday, 11 August 2025.
A study in Vienna highlights the effectiveness of community pharmacy-based screenings, revealing 51% of tested individuals have undiagnosed cardiovascular risks, yet follow-up rates remain low.

Introduction to Point-of-Care Testing

Point-of-care testing has emerged as a critical component in detecting cardiovascular risk factors early, as demonstrated by a recent study conducted in Viennese community pharmacies. From November 1 to December 31, 2024, a cross-sectional analysis revealed a significant proportion of undiagnosed individuals with these risk factors, highlighting gaps in traditional healthcare approaches [1].

Significance of Pharmacy-Based Screenings

Community pharmacy-based screenings not only provide accessible points for health interventions but also foster early detection of conditions that might otherwise remain unnoticed. The study showed that 51% of participants were identified with increased cardiovascular risk factors, underscoring the need for more widespread implementation of similar screening programs [1].

Challenges and Follow-Up Gaps

Despite the successes in initial risk detection through community pharmacies, the study identified a substantial gap in follow-up care. Only 57% of those contacted for follow-up attended, and just 43% received modified pharmacotherapy, indicating a need for improved integration with primary healthcare systems [1].

Cost-Benefit Analysis of Preventive Measures

Implementing pharmacy-based point-of-care testing can be a cost-effective strategy in preventive medicine. Early detection and management of cardiovascular risks can reduce long-term healthcare costs by preventing serious complications and hospital admissions [2][3]. Furthermore, this approach aligns with the growing recognition of community pharmacies as vital partners in public health [4].

Integration with Innovative Technologies

Incorporating digital tools and electronic health records with point-of-care testing amplifies the impact of these interventions. Such integration allows for real-time data sharing and enhances the precision of health assessments, ultimately leading to better patient outcomes [5].

Bronnen

point-of-care testing cardiovascular risk